International Guidelines for Bioequivalence of Systemically Available Orally Administered Generic Drug Products: A Survey of Similarities and Differences
Assessment of average, population and individual bioequivalence in two- and four-period crossover studies
Kullback–Leibler divergence for evaluating bioequivalence